These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 29150592)

  • 1. The Influence of Genetic Stability on
    Dos Reis TF; Silva LP; de Castro PA; Almeida de Lima PB; do Carmo RA; Marini MM; da Silveira JF; Ferreira BH; Rodrigues F; Malavazi I; Goldman GH
    G3 (Bethesda); 2018 Jan; 8(1):265-278. PubMed ID: 29150592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Aspergillus fumigatus Mismatch Repair
    Dos Reis TF; Silva LP; de Castro PA; do Carmo RA; Marini MM; da Silveira JF; Ferreira BH; Rodrigues F; Lind AL; Rokas A; Goldman GH
    mSphere; 2019 Aug; 4(4):. PubMed ID: 31391280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insight into the Significance of Aspergillus fumigatus cyp51A Polymorphisms.
    Garcia-Rubio R; Alcazar-Fuoli L; Monteiro MC; Monzon S; Cuesta I; Pelaez T; Mellado E
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29632011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contributions of both ATP-Binding Cassette Transporter and Cyp51A Proteins Are Essential for Azole Resistance in Aspergillus fumigatus.
    Paul S; Diekema D; Moye-Rowley WS
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28264842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Aspergillus fumigatus Damage Resistance Protein Family Coordinately Regulates Ergosterol Biosynthesis and Azole Susceptibility.
    Song J; Zhai P; Zhang Y; Zhang C; Sang H; Han G; Keller NP; Lu L
    mBio; 2016 Feb; 7(1):e01919-15. PubMed ID: 26908577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic Analysis Using an Isogenic Mating Pair of Aspergillus fumigatus Identifies Azole Resistance Genes and Lack of MAT Locus's Role in Virulence.
    Losada L; Sugui JA; Eckhaus MA; Chang YC; Mounaud S; Figat A; Joardar V; Pakala SB; Pakala S; Venepally P; Fedorova N; Nierman WC; Kwon-Chung KJ
    PLoS Pathog; 2015 Apr; 11(4):e1004834. PubMed ID: 25909486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Vitro Biochemical Study of CYP51-Mediated Azole Resistance in Aspergillus fumigatus.
    Warrilow AG; Parker JE; Price CL; Nes WD; Kelly SL; Kelly DE
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7771-8. PubMed ID: 26459890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Zn2-Cys6 Transcription Factor AtrR Plays a Key Role in an Azole Resistance Mechanism of Aspergillus fumigatus by Co-regulating cyp51A and cdr1B Expressions.
    Hagiwara D; Miura D; Shimizu K; Paul S; Ohba A; Gonoi T; Watanabe A; Kamei K; Shintani T; Moye-Rowley WS; Kawamoto S; Gomi K
    PLoS Pathog; 2017 Jan; 13(1):e1006096. PubMed ID: 28052140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cdr1B efflux transporter is associated with non-cyp51a-mediated itraconazole resistance in Aspergillus fumigatus.
    Fraczek MG; Bromley M; Buied A; Moore CB; Rajendran R; Rautemaa R; Ramage G; Denning DW; Bowyer P
    J Antimicrob Chemother; 2013 Jul; 68(7):1486-96. PubMed ID: 23580559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical epidemiology of pulmonary aspergillosis in hospitalized patients and contribution of Cyp51A, Yap1, and Cdr1B mutations to voriconazole resistance in etiologic Aspergillus species.
    Salehi Z; Sharifynia S; Jamzivar F; Shams-Ghahfarokhi M; Poorabdollah M; Abtahian Z; Nasiri N; Marjani M; Moniri A; Salehi M; Tabarsi P; Razzaghi-Abyaneh M
    Eur J Clin Microbiol Infect Dis; 2023 Jul; 42(7):853-864. PubMed ID: 37142789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SREBP-dependent triazole susceptibility in Aspergillus fumigatus is mediated through direct transcriptional regulation of erg11A (cyp51A).
    Blosser SJ; Cramer RA
    Antimicrob Agents Chemother; 2012 Jan; 56(1):248-57. PubMed ID: 22006005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic perspective of triazole resistance in clinical and environmental Aspergillus fumigatus isolates without cyp51A mutations.
    Sharma C; Nelson-Sathi S; Singh A; Radhakrishna Pillai M; Chowdhary A
    Fungal Genet Biol; 2019 Nov; 132():103265. PubMed ID: 31465846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of the novel antifungal compound F901318 against difficult-to-treat Aspergillus isolates.
    Buil JB; Rijs AJMM; Meis JF; Birch M; Law D; Melchers WJG; Verweij PE
    J Antimicrob Chemother; 2017 Sep; 72(9):2548-2552. PubMed ID: 28605488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fitness Studies of Azole-Resistant Strains of Aspergillus fumigatus.
    Valsecchi I; Mellado E; Beau R; Raj S; Latgé JP
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7866-9. PubMed ID: 26416854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First determination of azole resistance in Aspergillus fumigatus strains carrying the TR34/L98H mutations in Turkey.
    Özmerdiven GE; Ak S; Ener B; Ağca H; Cilo BD; Tunca B; Akalın H
    J Infect Chemother; 2015 Aug; 21(8):581-6. PubMed ID: 26048062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative Analysis of Single-Nucleotide Polymorphism for Rapid Detection of TR34/L98H- and TR46/Y121F/T289A-Positive Aspergillus fumigatus Isolates Obtained from Patients in Iran from 2010 to 2014.
    Mohammadi F; Hashemi SJ; Zoll J; Melchers WJ; Rafati H; Dehghan P; Rezaie S; Tolooe A; Tamadon Y; van der Lee HA; Verweij PE; Seyedmousavi S
    Antimicrob Agents Chemother; 2016 Jan; 60(1):387-92. PubMed ID: 26525787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in In Vitro Susceptibility Patterns of Aspergillus to Triazoles and Correlation With Aspergillosis Outcome in a Tertiary Care Cancer Center, 1999-2015.
    Heo ST; Tatara AM; Jiménez-Ortigosa C; Jiang Y; Lewis RE; Tarrand J; Tverdek F; Albert ND; Verweij PE; Meis JF; Mikos AG; Perlin DS; Kontoyiannis DP
    Clin Infect Dis; 2017 Jul; 65(2):216-225. PubMed ID: 28379304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspergillus fumigatus harbouring the sole Y121F mutation shows decreased susceptibility to voriconazole but maintained susceptibility to itraconazole and posaconazole.
    Lescar J; Meyer I; Akshita K; Srinivasaraghavan K; Verma C; Palous M; Mazier D; Datry A; Fekkar A
    J Antimicrob Chemother; 2014 Dec; 69(12):3244-7. PubMed ID: 25125676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted gene disruption of the 14-alpha sterol demethylase (cyp51A) in Aspergillus fumigatus and its role in azole drug susceptibility.
    Mellado E; Garcia-Effron G; Buitrago MJ; Alcazar-Fuoli L; Cuenca-Estrella M; Rodriguez-Tudela JL
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2536-8. PubMed ID: 15917566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring azole antifungal drug resistance in Aspergillus fumigatus with special reference to resistance mechanisms.
    Chowdhary A; Sharma C; Hagen F; Meis JF
    Future Microbiol; 2014; 9(5):697-711. PubMed ID: 24957095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.